Guoxin Health leads weekly institutional surveys as 139 firms probe its AI-driven health services growth
Nearly 100 stocks were surveyed by institutions in the past week, with Guoxin Health (000503) attracting 139 institutions, including 31 securities firms, 47 private equity funds, and 10 insurance companies. Guoxin Health attributed its health services revenue growth to chronic disease management and AI integration, and reported progress on the National Healthcare Security Administration's personal medical cloud project. Other high-growth stocks like Fushun Shares, Bojie Shares, and Huabao Shares also drew interest. Surveyed stocks rose an average of 0.27% for the week.
Editorial responsibility
- No named human review is recorded for this page.
- Reports are grouped by semantic similarity and deterministic rules. Language models may assist titles, summaries, translation and cross-source analysis; the page reads the event directly, while its address stays stable when the title changes.
- Summary covers the current reports
Cross-source coverage
Reporting timeline
139 Institutions Survey Guoxin Health; Other Profit-Surge Stocks Eyed
A recent survey by Securities Times shows that nearly 100 stocks were visited by institutional investors in the past week, with Guoxin Health (000503) attracting the most attention from 139 institutions, including 31 securities firms, 47 private equity funds, and 10 insurance companies. During the survey, Guoxin Health attributed its rapid health services revenue growth to the continued rollout of chronic disease management and health management businesses, as well as AI integration. The company also reported progress on the National Healthcare Security Administration's personal medical cloud project, for which it was selected to lead implementation planning. Other stocks with surging earnings were also surveyed. Fuchun Co. expects a 658%-785% surge in net profit for the first three quarters of 2026, driven by its new energy lithium battery electrolyte additive business. Bojie Co. reported a 7-fold increase in first-half net profit, with new orders in the big data and AI computing sector up nearly 350%. Huabao Co. attributed its recent stock price surge to improved earnings, new tobacco product supply deals, and low valuations. Surveyed stocks rose an average of 0.27% for the week, with Huning Co., Entive Smart, and Changlan Cable among the top gainers.
Over 100 Institutions Survey Guoxin Health; Other High-Growth Stocks Targeted
A recent survey by Securities Times shows nearly 100 stocks were visited by institutions in the past week, with Guoxin Health (000503) attracting the most attention from 139 institutions, including 31 securities firms, 47 private equity funds, and 10 insurance companies. During the survey, Guoxin Health attributed its rapid health services revenue growth to the continued advancement of chronic disease management and health management businesses, particularly in Shandong Province. The company also reported progress on the National Healthcare Security Administration's personal medical cloud project, where it leads implementation plan drafting. Other stocks with surging earnings were also surveyed. Fuchun Co. expects a 658%-785% year-on-year increase in net profit for the first three quarters of 2026, driven by its new energy lithium battery electrolyte additive business. Bojie Co. reported a seven-fold increase in first-half net profit, with new orders in big data and AI computing power surging nearly 350% year-on-year. Huabao Co. attributed its recent stock price surge to improved first-half performance, entry into global tobacco supply chains, and low valuation. The average stock price of surveyed companies rose 0.27% for the week, with Huning Co., Entive Smart, and Changlan Cable leading gains. Huning Co. highlighted a government policy on elevator retrofitting as a key external positive. Entive Smart confirmed the termination of a cooperation agreement with Wuxian Qiongguan, stating the computing power business has been taken over by new clients. Changlan Cable detailed its expansion into liquid cooling technology as an extension of its insulation materials business.
Read sourceGuoxin Health Leads Investor Surveys; Profit-Surge Stocks Like Fushun Shares Attract Attention
A recent survey by Securities Times shows nearly 100 stocks were surveyed by institutions in the past week, with Guoxin Health (000503) receiving the most attention from 139 institutions, including 31 securities firms, 47 private equity funds, and 10 insurance companies. During the survey, Guoxin Health attributed its rapid health services revenue growth to the continued rollout of chronic disease management and health management services, and noted progress on the national medical insurance cloud project, for which it was selected to lead implementation planning. Other stocks with surging profits also drew institutional interest. Fushun Shares expects net profit of 350-430 million yuan for the first three quarters of 2026, up 658%-785% year-on-year, driven by its new energy lithium battery electrolyte additive products. Bojie Shares reported a more than sevenfold increase in first-half net profit, with new orders in the big data and AI computing sector growing nearly 350% year-on-year in the first half of 2026. Huabao Shares attributed its recent stock price surge to improved first-half performance, entry into global tobacco supply chains, and low sector valuations. The average stock price of surveyed stocks rose 0.27% in the past week, with Huning Shares, Yidian Intelligent, and Changlan Cable leading gains.
Read sourceShow 3 older updatesHide older updates
139 Institutions Survey Guoxin Health; Profit Surge Stocks Attract Investor Attention
A recent survey by Sina Finance shows that nearly 100 stocks were surveyed by institutions in the past week, with Guoxin Health (000503) attracting the most attention from 139 institutions, including 31 securities firms, 47 private equity funds, and 10 insurance companies. During the survey, Guoxin Health attributed its rapid health services revenue growth to the continued advancement of chronic disease management and health management businesses, as well as the integration of AI technology. The company also reported progress on the national medical insurance cloud project, where it was selected to lead the implementation plan. Other stocks with significant profit surges, such as Fuxiang Co., Bojie Co., and Huabao Co., also drew institutional interest. Fuxiang Co. expects a 658%-785% year-on-year increase in net profit for the first three quarters of 2026, driven by its new energy lithium battery electrolyte additive products. Bojie Co. reported a sevenfold increase in first-half net profit, with new orders in the big data and AI computing power sector surging nearly 350% year-on-year. Huabao Co. attributed its recent stock price surge to improved first-half performance, entry into global tobacco supply chains, and low sector valuations. The average stock price of surveyed stocks rose 0.27% for the week, with Huning Co., Yidian Intelligent, and Changlan Technology leading gains. Huning Co. highlighted a government policy on elevator renovations as a key external利好. Yidian Intelligent confirmed the termination of a cooperation agreement with WuXiangWenQian, stating it was a normal business decision. Changlan Technology outlined its strategy to expand into the liquid cooling industry, leveraging its expertise in insulation materials.
Read sourceNearly 100 Stocks Surveyed by Institutions in Past Week; Gosuncn Health Leads in Number of Surveyors
According to a report from Stockstar Securities News on September 26, nearly 100 stocks were surveyed by institutions in the past week, with Gosuncn Health (000503) attracting the most attention from 139 institutions, including 31 securities firms, 47 private equity funds, and 10 insurance companies. During the survey, an institution asked about the rapid revenue growth in the company's health services business in the half-year report. Gosuncn Health attributed this primarily to the continued progress of its chronic disease management and health management operations. The company stated it is leveraging its long-term accumulation in the medical, pharmaceutical, and insurance sectors to improve service capabilities and integrate AI technology to enhance efficiency and user experience. Its chronic disease management business in Shandong Province is progressing steadily. Other stocks with surging performance, such as Fuxiang Co., Bojie Co., and Huabao Co., also received institutional surveys recently. On average, the surveyed stocks rose 0.27% over the past week, with Huning Co., Yitian Intelligent, and Changke Technology leading the gains.
Read sourceNearly 100 Stocks Surveyed in Past Week; China Reform Health Management Leads in Number of Institutions
According to a report from stockstar_securities_news on September 26, nearly 100 stocks were surveyed by institutions in the past week, with China Reform Health Management (000503) attracting the most attention from 139 institutions, including 31 securities firms, 47 private equity funds, and 10 insurance companies. During the survey, an institution asked about the rapid revenue growth in the company's health services business in the half-year report. China Reform Health Management attributed this to the continued progress of chronic disease management and health management services. The company stated it is leveraging its long-term accumulation in the medical, pharmaceutical, and insurance sectors to improve its chronic disease management service system, strengthen supply guarantees, platform support, and intelligent service capabilities, and actively promote the integration of AI technology with health service scenarios to enhance service efficiency and user experience. The company noted that its chronic disease management business in Shandong Province is progressing steadily. Other stocks with surging performance, such as Fuxiang Co., Bojie Co., and Huabao Co., have also recently received institutional surveys. On average, the surveyed stocks rose 0.27% over the past week, with Huning Co., Yitian Intelligent, and Changlan Technology leading the gains.
Read source